# Use of lanreotide for the treatment of gastrointestinal fistulae.

> PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-21135689-lanreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-11-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-21135689-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21135689-lanreotide-v1.json
- Content SHA-256: `2d1d38e8af848f896e8d1d19a1e6c7f834ac75b2c00e2d6681f0b2869493209c`

## Claims and source pins

### Headline

Use of lanreotide for the treatment of gastrointestinal fistulae. ([`pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387`](#source-pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387))

### Summary

PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387`](#source-pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387))

### Paragraph 1

PubMed lists PMID 21135689 in Annals of surgery as Letter, Comment, with publication-date metadata of 2011-01 (month precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387`](#source-pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387`](#source-pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387))

## Sources

<a id="source-pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387"></a>
- **Use of lanreotide for the treatment of gastrointestinal fistulae. · retained source version 1:2016-11-25:current:1cfb22a9d3870b7e907b6c3480a09dd7e6742cf8575e41228be2f61f4790dd9c** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/21135689/) (`pubmed-observation-pmid-21135689-2016-11-25-1cfb22a9d387`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Use of lanreotide for the treatment of gastrointestinal fistulae." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-21135689-lanreotide-v1.json SHA-256: 2d1d38e8af848f896e8d1d19a1e6c7f834ac75b2c00e2d6681f0b2869493209c.